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PENCIRIAN DAN SIFAT-SIFAT BAGI HIDROKSIAPATIT 
TERKARBONAT YANG DISINTESIS DAN DISINTER 
ABSTRAK 
 Hidroksiapatit terkarbonat (CHA) jenis B telah berjaya disintesis melalui 
kaedah pengemulsian nano melalui teknik titisan (DW) dan tuangan langsung (DP). 
Kandungan karbonat dalam DP (8.60%) adalah lebih tinggi daripada DW (7.85%). 
Kedua-dua teknik menghasilkan serbuk bersaiz nano dengan bentuk partikel yang 
bervariasi. Adalah didapati pada suhu rendah (≤ 40°C), serbuk CHA yang dihasilkan 
berbentuk sudut, manakala di atas suhu kritikal ini, campuran hablur bersudut dan 
rod terhasil. Suhu bilik adalah lebih baik kerana ia menghasilkan serbuk bersaiz nano 
dengan luas permukaan yang terbesar. Pensinteran kemudiannya dijalankan ke atas 
sampel CHA tulen, CHA+Mg(OH)2, HA, dan HA+Mg(OH)2 kemudian disejuk 
dengan dan tanpa kehadiran gas CO2 basah untuk menghasilkan jenis penggantian 
karbonat yang berbeza di dalam struktur. CHA jenis B berjaya dikekalkan dengan 
pensinteran CHA dan CHA+Mg(OH)2 pada suhu 700-900°C, dengan 
CHA+Mg(OH)2 mencapai ketumpatan optimum pada 800°C (CM2C). Sampel lain 
memerlukan suhu lebih tinggi untuk penumpatan. Kandugan karbonat juga adalah 
berbeza dengan CM2C yang tertinggi iaitu 4.30 wt%. CHA jenis AB dan A 
dihasilkan apabila HA+Mg(OH)2 dan HA digunakan sebagai bahan permulaan. 
Penggunaan Mg(OH)2 berjaya menurunkan suhu pensinteran dan membantu 
penumpatan sampel melalui Persinteran Fasa Cecair. Penggunaan gas CO2 basah 
juga telah berjaya menggantikan karbonat yang terurai daripada sampel semasa 
persinteran. Nilai kekerasan, K1c, dan DTS bagi sampel paling tumpat CM2C adalah 
2.37 GPa, 3.27 MPa.m1/2, and 22.95 MPa, dengan kebioaktifan yang lebih baik 
dengan pembentukan lapisan apatit yang lebih cepat. Oleh yang demikian, sifat CHA 
tersinter yang lebih baik telah berjaya dihasilkan di dalam kajian ini.  
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CHARACTERIZATION AND PROPERTIES OF SYNTHESIZED AND 
SINTERED CARBONATED HYDROXYAPATITE 
ABSTRACT   
 B-type Carbonated Hydroxyapatite (CHA) was successfully synthesized via 
nanoemulsion method, through dropwise (DW) and direct pouring (DP) techniques.
 
The carbonate content in DP (8.60%) was higher than DW (7.85%). Both techniques 
produced nano-sized powders with variation in shapes of particles. It was also found 
that at temperature (≤ 40°C), the CHA powders were angular while above this 
critical temperature mixture of rods and angular shape was produced. Room 
temperature synthesis was better as they produced nano-size CHA with larger surface 
area. Sintering was then performed on pure CHA, CHA+Mg(OH)2, HA and 
HA+Mg(OH)2, samples which was cooled down with and without wet CO2 
atmosphere to produce different type of carbonate substitution in the structure. Pure 
B-type CHA was successfully retained when pure CHA and CHA+Mg(OH)2 was 
sintered at 700-900°C, with the latter reaching optimum densification at temperature 
of 800°C (CM2C). Other samples required higher temperature for densification. The 
carbonate content was also different with CM2C having highest 4.30 wt%. AB-type 
CHA and A-type CHA was formed for densest sintered samples using HA+Mg(OH)2 
and HA as starting material.
 
The use of Mg(OH)2 had successfully reduce the 
sintering temperature and improve the densification of the sintered samples through 
Liquid-Phase Sintering.
 
The use of wet CO2 atmosphere was successfull to 
compensate the carbonate loss during sintering.
 
The hardness, K1c, and DTS values 
obtained for densest CM2C were 2.37 GPa, 3.27 MPa.m1/2, and 22.95 MPa, 
respectively, and shows a better bioactivity by rapid formation of apatite crystals. 
Thus, an enhancement of sintered CHA properties was successfully achieved in this 
study.  
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CHAPTER 1 
INTRODUCTION 
1.1 Research Backgrounds 
 Bones are a dynamic and highly vascularized tissue which continuously remodel 
itself throughout the lifetime of an individual. Typically the bones assist in 
locomotion activity, ensure skeletons have sufficient load-bearing capacity, and 
protect delicate internal organs of the body as reported by Stevens (2008). However, 
bones are also prone to injury, defects and aging, resulting from many different 
causes. For example, trauma, infections, tumour and metabolism can result in bone 
injury which is a major public health problem (Best et al., 2008; Sopyan, 2009). 
Dental and orthopaedics treatments also require adequate bone supplies and therefore 
the interest in bone regeneration is increasing. As a result, bone grafting or bone 
substitute has become critical in orthopaedics surgery (Sutherland & Bostrom, 2003). 
Bone graft can be defined as implanted or transplanted bone from another part of 
the human body or mammal, or any synthetic material to reconstruct the bone defect. 
Bone graft should provide a good local and systematic compatibility, the capability 
of being substituted by bone and completely filling any defects (Schnettler et al., 
2004). Bone graft source can be adopted from another part of non-load bearing site 
of the indivual patients body (autograft), another human donor tissue (allograft), 
animals tissue (xenograft) or synthetic biomaterials (artificial bones). However, it is 
known that, autograft, allograft and xenograft have serious drawbacks to the patients 
(Hing, 2005; Stevens, 2008). Among others, the drawbacks include possibly infected 
by diseases, inadequate supplies and severe pain to the donor of the graft. 
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Worldwide, especially in United States, the need for bone grafting arose as the 
population age increases. Based from the data collected from hospitals treating hip 
fractures, both government and private hospitals, more than 300,000 hip and knee 
replacement surgeries have been performed mostly to senior citizens of the age 65. 
The number of hip fractures is expected to be 500,000 annually by the year 2040 as 
reported by The Malaysian Osteoporosis Society (MOS). In Malaysia, the overall 
incidence of hip fractures has been reported as 90 per 100,000 individuals (Lee & 
Khir 2007). The fracture rates are highest among the Chinese (160 per 100,000), 
followed by Indians (150 per 100,000) and Malays (30 per 100,000) based from the 
race-specific incidence data. Females were reported to be twice frequently affected 
compared to the male counterparts based from the data collected by the National 
Statistic Department. Hence,there has been the need to study on the production of 
artificial bones from biomaterials. Therefore, technological research has moved 
towards the synthesis of new substituting biomaterials mimicking biological bone 
tissue (Tampieri et al., 2005).  
Hydroxyapatite (HA) is one of the most widely used bioceramic in bone graft 
substitute, bone tissue engineering and drug delivery system (Suchanek et al., 2002). 
This is possible due to its biocompatibility, bioactivity, osteoconductivity and non-
toxicity properties (Bouyer et al., 2000; Afshar et al., 2003; Rajabi-Zamani et al., 
2008). It is also greatly influenced by its similarity in chemical structure with 
biological apatite, which comprises of the mineral phase of calcified tissue in the 
enamel, dentin and bone (Murugan & Ramakrishna, 2006). However, stoichiometric 
HA has been reported to have limited ability to form an interface and its resorption in 
vivo is too sluggish to induce a massive formation of a new bone tissue (Kovaleva et 
al., 2008). Stoichiometric synthetic HA also does not degrade significantly but rather 
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remains as a permanent fixture susceptible to long term failure (Ishikawa et al., 
2003). 
One way to enhance biological properties of HA implant is through the chemical 
modification of HA. Carbonated hydroxyapatite (CHA) has been reported to be 
superior to pure HA for bioresorbable implants (Kovaleva et al., 2008).  This is 
because human and animal bone mineral have been shown to contain significant 
amounts of carbonate (Tadic et al., 2002; Landi et al., 2004; Krajeswari et al., 2005). 
It is therefore claimed that the biological apatite be referred as carbonated 
hydroxyapatite (CHA). Generally, the amount of carbonate in CHA is about 2-8 wt% 
of the calcified tissue and may vary depending on the age factor (Merry et al.,1999; 
Barralet et al., 2000; Landi et al., 2003). Carbonate ion can substitute either in the 
hydroxyl groups (A-type) or the phosphate groups (B-type) or it can also 
simultaneously substitutes both hydroxyl and phosphate groups (AB-type) as 
reported by Lafon et al. (2008) and Tkachenko and Zyman (2008). The presence of 
carbonate in the apatite lattice is known to increase chemical reactivity and would 
probably contribute to the ease of resorption in bony tissue (Vallet-Regi & Gonzalez-
Calbet, 2004). The incorporation of carbonate into the host HA would cause an 
increased in solubility, decrease in crystallinity, change in crystal morphology and 
better biological activity (Porter et al., 2005). With this, it is currently accepted that 
CHA is a prospective material for medicine in order to mimic the composition of 
natural bone (Kovaleva et al.,2008). 
In general, there are various synthesis routes that have been explored to 
synthesize CHA and among others include chemical precipitation, nanoemulsion, 
and hydrothermal synthesis. A-type CHA is commonly prepared by exposing HA at 
high temperature under flow of carbon dioxide. On the other hand, B-type CHA is 
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normally synthesized using wet method from precipitation reaction in aqueous media 
with control parameters such as pH, temperature, and reagent concentration (Lafon et 
al., 2008).  
Synthetic CHA of excellent bioactivity, biocompatibility and osteoconductivity 
has already attracted much attention in the field of tissue engineering as a 
bioresorbable bone graft substitutes as well as for dental replacement and repairation. 
However, the mechanical properties of these apatite ceramics are known to be less 
than that of the cortical bone (Nakamura, 1996). Load bearing implants applications 
are hindered by the low strength and toughness of CHA, especially in wet 
environment, whereas applications of bulk CHA for non structural implants such as 
ossicles in ear have no particular difficulties. 
1.2 Problem Statement 
Typically, heat treatments are widely used either to prepare dense or porous 
bulks, granules and during plasma spraying of coatings. Basically, the strength of 
CHA was found to be strongly dependent on the internal porosity and this can be 
avoided with proper sintering. It can be anticipated that, increasing the density by 
sintering will decrease the amount of porosity (Morgan et al., 1997).  Typically, a 
high temperature thermal treatment is required to produce densified ceramic part 
from powders. However, the limited thermal stability of the CHA is a challenge of 
major importance as reported by Barralet et al. (2000) and Panda et al. (2003). The 
presence of carbonate ions in HA structure influence the decomposition and 
sinterability of CHA. Poor control of  heat treatment of CHA would result in 
carbonate loss, leading to partial or total decomposition of the material and hence 
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would affect the physical and mechanical properties of the synthetic material (Landi 
et al., 2000). 
Therefore, the aim of this work is to produce and sinter dense CHA with good 
physical and mechanical properties. In this study, the introduction of Mg(OH)2 as 
sintering aid improve the sintering and thus it is hoped that higher densification and 
good mechanical properties could be achieve at a much lower sintering temperature 
in order to avoid decomposition of CHA. The introduction of wet CO2 is intelligently 
designed to compensate the carbonate loss due to decomposition during sintering. 
Besides that, it is also hoped that the CHA formed will be mechanically, biologically, 
chemically and structurally similar to the mineral phase in bone. 
1.3 Objective of the Research 
The aim of this reseach is to produce CHA biomaterial with good physical, 
mechanical and biological properties in order to mimic the natural human bone 
mineral. With this main goal, the following objectives were set:  
I. To synthesize CHA powders by two different techniques, i.e. dropwise 
and direct pouring by nanoemulsion method and characterization of the 
powder. 
II. To synthesize CHA at four different temperatures (RT, 40, 60, and 80°C) 
and characterize the powder. 
III. To study the effect of sintering conditions on CHA with and without the 
addition sintering aid, on the physical, and mechanical properties of the 
sintered samples. 
IV. To investigate the bioactivity of the sintered samples using Simulated 
Body Fluid (SBF) solution. 
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1.4 Scope of works 
Generally, this work can be divided into four main parts. Fig.1.1 Flowchart the 
scope of work involved in this study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.1 Flowchart of the research work 
Synthesis of CHA powder via different 
techniques by nanoemulsion 
Dropwise Direct Pouring 
Characterize and optimize synthesis techniques 
Synthesis of CHA powder at 
different synthesis temperatures 
T= RT, 40, 
60, 80°C 
Characterize and optimize synthesis temperatures 
Preparation of bulk CHA 
Sintering at different temperature 
Optimize sintering parameters 
Bioactivity Test (in vitro) 
(Part 1) 
Cooling down without 
wet CO2  atmosphere 
Cooling down with wet 
CO2 atmosphere 
With addition of Mg(OH)2 Without addition of Mg(OH)2 
(Part 2) 
(Part 3) 
(Part 4) 
Characterization: 
 Physical  
 Chemical and elemental 
 Mechanical 
  
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CHAPTER 2 
LITERATURE REVIEW 
2.0 Introduction  
 Different reasons could cause injury to bone, and this includes severe missing 
piece of bone or trauma cases, total hip revisions, infections, cancerous and tumours, 
metabolism, and in the correction of large bony defects involving damage to bone 
(Sutherland & Bostrom, 2003). Thus, the use of bone substitutes has become 
clinically important as the demands had increased dramatically over the last few 
decades.  The needs of bone implants arose as the elderly population increased with 
escalating geriatric health expenditure also in rapidly developing country (Lee et. al, 
1993). Worldwide, the total hip fractures in 1990 were reported to be 1.26 million. 
This was dominated by female that was estimated to be about 917,000 while male 
was only about 338,000. The number of hip fractures is estimated to be 
approximately double in the year 2025 which involve 2.6 million patients and 4.5 
million by 2050. The major demographic changes will occur in Asia. About 26% of 
all hip fractures occurred in Asia in 1990 and is estimated to rise to higher number in 
future. Gullberg et al. (1997) also reported that the socioeconomic impact of hip 
fractures will increase markedly throughout the world, particularly in Asia. Hence, 
the needs to develop new substituting artificial bones from biomaterials are getting 
more important, particularly in developing countries.  
 Bone grafting was firstly introduced in the 1800s, to replace missing part of 
the bone with material from either the patients own body (autograft), or that of a 
donor (allograft) obtained from a bone bank (Czitrom & Gross, 1992; Meeder & 
Eggers, 1994). Alternatively, bone grafts can also be adopted from the mammalians 
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species as reported by Neumann and Epple (2006). However, the various suggested 
bone grafts has serious drawbacks to be considered. Allograft, although being 
considered as the gold standard of all bone substitution materials, however have 
limitations to the amount of collectable bone from donors (Schieker et al., 2006; Ana 
et al., 2010). Moreover, this method would normally require a second operation 
which would be costly, time consuming and causes additional trauma (Ishikawa et 
al., 2003). In the case of allograft and xenograft, there are potentially high risk of 
transmitting diseases as well as variety of bacterial and virus infections, including 
those that cause AIDS or hepatitis to patients (Tancred et al., 1998; Schnettler et al., 
2004).  
 Bioceramics are classified as inorganic ceramics that are used in medical and 
dental practices for the human body (Bilotte, 2003). Ceramics and composite based 
on calcium phosphate are known to be the potential bioceramic materials for bone 
graft substitute (BGS). In recent years, synthetic hydroxyapatite (HA) has been 
extensively use as BGS materials due to its biocompatibility, bioactivity, 
osteoconductivity and it possess similar characteristic with the biological bone. 
However, reports showed that human bone differs in composition with stoichiometric 
synthetic HA in that it contains 2-8 wt% of carbonate ions (Merry et al., 1999; Tadic 
et al., 2002; Landi et al., 2004; Kovaleva et al., 2008). Hence, there have been drive 
for researchers to head towards the production of synthetic carbonated 
hydroxyapatite (CHA), instead of pure synthetic HA, that would be used in BGS 
application. Additions of other dopants for specific functions have also been 
investigated.  
In general, the aims of this review are to provide a strong fundamental 
understanding and overview of the structure and properties of natural bone tissues 
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followed by the important of biomaterial in BGS application. Bioceramic which are a 
part of biomaterials will be also discussed in detail. The review then will be focussed 
further on calcium phosphate based bioceramics, in particular the hydroxyapatite and 
carbonated hydroxyapatite. This will then be followed by the review on the synthesis 
of CHA via various methods. And the final part of this review then described some 
available sintering techniques and conditions in order to produce highly densified 
CHA, as intended in this study.  
2.1 Biological Bones 
 Bone is a typical calcified tissue of mammals; which are in different shapes 
and sizes from macro- to micro- and to nanoscale, to protect and to provide 
mechanical support for the body (Currey, 2005; Cui and Ge, 2007). Bone is a 
complex living tissue, having elegant structure of distinct levels of hierarchical 
structural units (Stevens & George, 2005; Roveri & Lafisco, 2010) as shown in Fig. 
2.1. In simple terms, the bone can be described as a biocomposite of organic phase 
(based on collagen) in which calcium-containing inorganic crystals are embedded in 
soft protein matrix (Best et al., 2008, Meyes et al., 2008).  
 
Fig. 2.1 Hierarchical structural units of bone on different scales, including 
extracellular matrix (Stevens & George, 2005) 
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The bone structure could be fibrous, laminar, particulate and porous and are 
present at different scale of size (Dorozhkin, 2009). Though the dimensions of 
biological apatite crystals reported in the literature varies due to the different 
treatment methods and analytical techniques, it is generally found that the values in 
the ranges of 30-50 nm in length, 15-30 nm in width and 2-10 nm in thickness. 
Nanometer scales appear to be as important to bone as to ensure optimum strength 
and maximum tolerance of flaws (Gao et al., 2003; Gupta et al., 2006). 
From a material engineering point of view, bone is a porous composite 
material surrounded by bone cells and blood vessels embedded in a biphasic matrix 
of organic and inorganic elements (Dorozhkin, 2009). Bone also contains bone-
forming cells, which are known as osteoblasts and osteoclasts which are the bone-
resorbing cells and various osteoinductive growth factors and molecules. Generally, 
the weight proportions of the major component of human bone are 60- 70% mineral 
substances, 20-30% of collagen and the other organic components, while the 
remaining is water (Weiner & Zaslansky, 2004). 
Over two decades, hydroxyapatite (HA) has been ascribed as the synthetic 
material closely resembles bone composition. However, natural bone mineral is 
relatively an impure version of HA, as it differs in composition from the 
stoichiometric HA in that it contains additional ions, of which carbonate is the most 
abundant species (Ishikawa, 2010). The carbonate content varies depending on the 
individuals age (Landi et al., 2003; Kovaleva et al., 2008). Besides the main ions of 
Ca2+, PO 34 , OH
-
 and CO 23 , there are other of minority ions which includes Mg
2+
, 
K+, Na+, F-, and Cl- as reported by LeGeros (1994) and Slosarczyk et al. (2010). This 
is depicted in Table 2.1 showing the elements of adult human hard tissues.  
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Table 2.1 Human hard tissue components of the human adult (LeGeros, 1994) 
Constituent Composition (wt%) 
Bone Enamel Dentin 
Calcium, Ca2+ 34.8 36.5 35.1 
Phosphorus, P 15.2 17.7 16.9 
Sodium, Na+ 0.9 0.5 0.6 
Magnesium, Mg2+ 0.72 0.44 1.23 
Potassium, K+ 0.03 0.08 0.05 
Carbonate, CO 23  7.4 3.5 5.6 
Fluoride, F- 0.03 0.01 0.06 
Chloride, Cl- 0.13 0.30 0.01 
Pyrophosphate, P3O 47  0.07 0.022 0.1 
Total inorganic 65 97 70 
Total organic 25 1.5 20 
Absorbed H2O 10 1.5 10 
 
2.2 Types of bones 
 In general, bones in human and other mammal bodies can be classified into 
two types that are the cortical bone and trabecular bone (Hench & Wilson, 1993). 
The cross section of the human bone is shown in Fig. 2.2 (Bandyopadyay et al., 
2006). Porosity and the unit microstructure determine the two types of bones.  
 
Fig. 2.2 Cross- sectional view of human bone (Bandyopadyay et al., 2006) 
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2.2.1 Cortical Bone 
 The cortical bone, also called the compact bone is the denser bone, consisting 
of parallel cylindrical units with porosity ranging between 5 to 10%. Cortical bone is 
primarily found in the shaft of long bones (femur, tibia, fibula, etc.) and forms the 
outer shell around the cancellous bone at the end of joints and the vertebrate (Meyes 
et al., 2008). The density of the cortical bone is reported to be around 1.99 g/cm3 
(Currey, 1998).  Safadi et al. (2009) defined cortical bone as the dense hard, calcified 
bone that forms the hard outer shell of a bone which surrounds the marrow cavity.  
2.2.2 Trabecular Bone 
 The trabecular bone or the cancellous bone, is the spongy type of bone. Its 
porosity ranges from 50 to 90%. It is normally found at the end of the long bones in 
vertebrate and in flat bones like the pelvis. Trabecular bone is like honeycomb in 
cross section and it is composed of short struts of bone material called trabeculae. 
The mechanical properties of trabecular bone are greatly dependent on its porosity 
and the way this porosity is structured. Besides that, the pores also perform other 
physiological functions and contain the marrow. Thus, bone is truly considered as 
multifunctional material (Hench & Wilson 1993; Meyes et al., 2008). 
2.2.3 Cortical bone versus Trabecular bone 
 The major mechanical property difference between trabecular and cortical 
bone is the effective stiffness. Trabecular bone is more compliant than cortical bone 
and it is believed to distribute and dissipate the energy from articular contact loads. 
Only 20% of the skeletal mass within the body was contributed by trabecular bone 
while cortical bone contributes the remaining 80%. Besides that, the trabecular bone 
has much greater surface area than cortical bone. A comparison between the general 
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features and mechanical properties of cortical bone and trabecular bone is listed in 
Table 2.2. Generally, the compressive strength, flexural strength and Young Modulus 
of cortical bones are higher than that of trabecular bone.  
Table 2.2 Comparison between structural features and mechanical properties of 
cortical bone and trabecular bone (Hench & Wilson, 1993; Keaveny, 1998) 
Properties Cortical Bone Trabecular Bone 
Volume Fraction 0.85- 0.95 0.05- 0.60 
Surface/ Bone Volume (mm2/mm3) 2.5 20 
Total Bone Volume (mm3) 1.4 x 106 0.35 x 106 
Total Internal Surface (mm2) 3.5 x 106 7.0 x 106 
Compressive Strength (MPa) 100- 230 2-12 
Flexural Strength (MPa) 50- 150 10- 30 
Strain to failure             1-3 5- 7 
Young Modulus (GPa) 7- 30 0.1- 2.0 
 
2.3 Bone Graft Substitute (BGS) 
 As discussed earlier, bone injury or damage can occur in many different 
ways, which include trauma, infections, tumours and metabolisms (Sutherland & 
Bostrom, 2003). It is known that skeletons support the body and also protection of 
vital organs, however, it is also susceptible to fractures as a result of injury and 
degenerative diseases which are often associated with aging. Thus, since the earliest 
of time, there has always been a need for the repair of damaged hard tissues (Best et 
al., 2008). Hence, bone graft substitute (BGS) has become critical in orthopaedic 
surgery.  
 Bone graft, firstly introduced in the 1800s with the earliest attempt was to 
replace missing bone with biomaterials, aimed to restore basic functions by repairing 
the defects due to injury or diseases (Czitrom & Gross, 1992; Meeder & Eggers, 
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1994). Bone grafts are generally used in combination with fixation devices in order 
to provide the mechanical stabilization during the healing process. Ideally, the graft 
should be able to replace the missing parts as well as to promote new bone in growth 
into the grafted area. This would reinforce the repaired area and at the same time 
building an interlock between natural bone and the grafted material. With time, the 
newly formed bone should also penetrate and replace much of the graft through a 
process called remodelling (Hing, 2005; Best et al., 2008). 
 Theoretically bone graft source can be adopted from another part of the 
patients body (autograft), from another individual tissue obtained from a bone bank 
(allograft), from other mammalian species (xenograft) or from synthetic biomaterial 
(Czitrom & Gross, 1992; Meeder & Eggers, 1994, LeGeros et al., 2006).  
2.3.1 Autogenous Bone Grafting 
 Autogenous bone grafting, also referred as autografting is regarded as the 
golden standard of bone grafting, as bone from another anatomic site of the patient 
is use to treat the defected bone of the patient himself (Togawa et al., 2004). 
 In autograft reconstruction, there will be no risk of transmission of diseases 
while the human body would accept its bodys component better from a donor. The 
fact that there is no risk transmission is very positive for autograft and is widely 
accepted among the patients as reported by Hing (2005). 
 However, autograft has several serious drawbacks where, the volume of bone 
that can be harvested from the patient is limited and the collectable bone is also 
limited in its form. Mata et al. (2002) and Ishikawa et al. (2003) reported that this 
method usually requires secondary operation procedure and this would be costly, 
time consuming and sometimes it might cause additional further trauma. Besides 
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that, autograft could also cause donor site morbidity, patella fractures, patella 
tendonitis and scar formation (Burg et al., 2000, Ana et al., 2010). 
2.3.2 Allogeneic Bone Grafting 
 Alternatively, allograft bone can be used where the bone graft source is 
adopted from donors. Modern allografting uses the material stored within the 
regulated bone banks (Sutherland & Bostrom, 2003).  Generally, freeze-drying of the 
allograft is used to decrease their antigenicity as well as to have extended period of 
time (Whang & Wang, 2003).  
 Using allograft tendon will allow the patient to avoid donor site morbidity, 
reduce surgical time, smaller incisions and availability of graft either in terms of 
cancellous, cortical or combination of each bone. Elderly people (over 45 years of 
age), those requiring repairmen of the bones and skeletally immature athletes are 
common candidates for allograft tendons. Allograft reconstruction also provides a 
safer choice to those patients who are at higher risk of complication under 
anaesthesia (Sutherland & Bostrom, 2003; Hing, 2005). 
 Nevertheless, tissue availability, graft cost, delayed graft incorporation, 
sterilization, and long term graft strength are some issues related to allograft. Disease 
transmission is also a major concern in allograft tissue (Bostrom & Mikos, 1997; 
Burg et al., 2000). Two diseases which are most feared patients that would receive 
allograft tissue are human immunodeficiency virus (HIV) and hepatitis, although the 
risks of transmitting these diseases are relatively small. Most of the time, there is 
delayed graft incorporation because the body fails to accept the foreign tissue. 
Besides that, blood group-incompatible in bone transplantation can also cause the 
development of antibodies within ABO systems (Schnettler et al., 2004). 
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2.3.3 Xenotransplantation 
 The transplantation of living cells, tissues or organs from other mammalian 
species to human is known as Xenotransplantation. Such cells, tissues or organs are 
called xenografts or xenotransplants. Normally, bone tissue is taken from cows or 
pigs as sources for xenograft. Similar with allograft, xenograft has high potential of 
transmitting diseases and cause permanent alteration to the genetic code of animals 
Vagaska et al., 2010). Pigs also have a shorter lifespan than human thus, their tissues 
ages at a different rate (Tancred et al., 1998). 
 Xenograft also has been a controversial issue since they were first attempted. 
The animal groups strongly oppose killing animals in order to harvest their organ for 
human use. There are also religious beliefs (Muslim, Jewish) which prohibits the use 
of pigs as xenograft source (Boneva et al., 2001; Sopyan, 2009). 
2.4 Biomaterials 
 Since there are serious drawbacks with bone graft substitutes, there has been 
requirement to produce synthetic materials. Hence, biomaterial is a synthetic material 
which is synthesized, used to replace part of living system and to function in intimate 
contact with living tissues (Park & Bronzino, 2003). It is a systematically and 
pharmacologically inert substance designed for implantation within or incorporation 
with living systems. Biomaterial is also defined as synthetic tissues intended to 
interface with the biological systems which would evaluate, treat, or replace any 
tissue, organ, or function of the body. By contrast, biological material is the bone 
matrix or tooth enamel, which is produced by a biological system.  
There is always confusion between biomaterial and artificial material. The 
latter are those materials which are in contact with the skin, for example the hearing 
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aids and wearable artificial limbs. Artificial material is not biomaterial since the skin 
act as the barrier with the external world (William, 1992; Park & Lakes, 2007). On 
the other hand, biomaterials are used in the body system, typically in contact with 
inner tissues.  
 The basic functions of biomaterials are to assist in healing defects, to correct 
abnormalities and to improve function (Vagaska et al., 2010). Biomaterials also play 
important roles in order to repair and reconstruction of damaged and worn out part of 
the human body or that caused by disease. The function and example of biomaterials 
in humans organ are summarized in Table 2.3. 
Table 2.3 Example and function of biomaterials in humans organ  
(Park & Lakes, 2007) 
Function 
 
Example Organ 
Replacement of diseased 
or damaged part 
Artificial hip joint, kidney 
dialysis machine 
Bone, kidney 
Assist in healing Sutures, bone plates and screws Bone 
Improve function Cardiac pacemaker, contact lens Heart, Eye 
Aid to diagnosis Probes, catheters Bladder 
 
 The successful implant of biomaterial in the body depends on factors such as 
the material properties, biocompatibility of the material used and design. The bodys 
immune system rejection of the implant and the unwanted effect of the implant upon 
the body can cause failure of the biomaterial, which leads to toxicity, inducing an 
inflammation and causing cancer. In order to be classified as biomaterial, the 
materials have to meet the following requirements, (1) Non-toxic; (2) Non-
carcinogenic; (3) Non-allergic; (4) Non-inflammatory; (5) Biocompatible; and (6) 
Bio-functional for life time (Desai et al., 2008). Table 2.4 list the classes and 
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example of materials used biomaterials, with their advantages and disadvantages, 
respectively.   
Table 2.4 Class of materials used as biomaterials (Bhat, 2005; Park & Lakes, 2007) 
Materials Advantages Disadvantages Examples 
Polymer 
(nylon, silicones, 
teflons) 
 Light 
 Resilient 
 Easy to fabricate 
 Deform with 
time 
 May degrade 
 Low mechanical 
strength 
Sutures, blood 
vessels, other 
soft tissue, hip 
socket 
Metals & Alloys 
(Titanium and its 
alloys, stainless 
steel, gold, cobalt-
chromium)  
 High impact 
strength 
 Tough 
 Ductile 
 High resistance to 
wear 
 May corrode 
 Difficult to 
fabricate 
 Low 
biocompatibility 
Joint 
replacement, 
bone plates 
and screw, 
dental root 
implants, 
orthopaedic 
load bearing 
Ceramics 
(Alumina, zirconia, 
calcium phosphate) 
 Good 
biocompatibility 
 Inert 
 Corrosion 
resistance 
 Biodegradable 
 Brittle 
 Not resilient 
 Weak in tension 
 Special 
technique are 
needed for 
fabrication 
Dental and 
orthopaedic 
implants, hip 
and knee 
prostheses 
Composite 
(Carbon-carbon, 
wire-or fibre 
reinforced bone 
cement) 
 Strong 
 Tailor made 
 
 Difficult to 
make 
Bone cement, 
dental resin 
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2.5 Bioceramics 
 Ceramic is defined as the art and science of making and using solid articles 
that have their essential components as inorganic and non-metallic materials that are 
been heat-treated (Kingery et al., 1976). In the past several decades, however, 
revolution had occurred in the use of ceramics to improve the health quality of 
human life. Researchers have developed a series of specially designed and fabricated 
ceramics for medical devices, and these are now referred to as bioceramics. Hence, 
the  class of ceramics used for repair and replacement of diseased and damaged parts 
of human musculoskeletal systems are known as bioceramics (Thamaraiselvi & 
Rajeswari, 2004). This include the use as to repair and reconstruction of arthritic or 
fractured joints cause by damaged or diseased of the human body, correct chronic 
spinal curvature and immobilize vertebrae in order to protect spinal cord. It is also 
used to replace parts of cardiovascular system, especially heart valves, and 
therapeutically for the treatment of tumours. The biomedical application of 
bioceramics is summarized in Table 2.5. 
Table 2.5 Biomedical Applications of Bioceramics                                
(Thamaraiselvi & Rajeswari, 2004) 
Devices Fuction Biomaterial 
Artificial total hip, knee, 
sheldow, elbow, wrist 
Reconstruct arthritic or 
fractured joints 
High-density alumina, 
metal bioglass coatings 
Bone plates, screws, 
wires 
Repair fractures Bioglass-metal fiber 
composite 
Permanently implanted 
artificial limbs 
Replace missing extremities Polysulfone-carbon fiber 
composite 
Vertebrae spacers and 
extendors 
Correct congesnital deformity Alumina 
 
Spinal fusion Immobilize vetebrae to protect 
spinal cord 
Bioglass 
 
End osseous tooth 
replacement implants 
Replaced disease, damaged or 
loosened teeth 
Alumina, dense 
hydroxyapatite 
Orthocontic anchors Provide posts for stress 
application required to change 
deformities  
Bioglass coated alumina 
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Bilotte (2003) reported that, bioceramics show better biocompatibility with 
tissue response when compared to polymeric or metallic biomaterials, and 
subsequently, they are being used as implants within bones, joints and teeth in the 
form of bulk materials of specific shape. However, despite their biocompatibility, 
there are also serious drawbacks where bioceramics are also known to be brittle, 
having low mechanical strength (in tension) and inferior workability. As a result, 
bioceramics are susceptible to failure with notches or microcracks because they do 
not deform plastically, and would fail easily (Bilotte, 2003).  
2.5.1 Biocompatibility 
 The term biocompatibility relates to the ability of the material to elicit 
appropriate biological response in the given application. This include, as minimal as 
possible, any adverse reactions which may ensue at the blood/material or 
tissue/material must be with high resistance to biodegradation. The surrounding 
environment should not cause degradation or corrosion of the biomaterial as this 
could result in loss of physical and mechanical properties (Wise, 1995). The 
biocompatibility of the implant is influenced by several factors, such as implant 
shape, size, material composition, roughness, charge and surface wettability. 
Biocompatible is believed to be in a dynamic mode and ongoing process rather than 
static (Brantley & Eliades, 2001).  
 Besides that, biocompatibility of the biomaterial should also mean it would 
not cause thrombus-formation, cause adverse immune response and alter plasma 
proteins so as to trigger undesirable reaction (Park & Bronzino, 2003).  
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2.5.2 Classification of Bioceramics 
 As mention earlier, bioceramics have been established as a group of materials 
for medical application, mainly for implants in orthopaedic surgery, maxillofacial 
surgery and for dental implants (Thamaraiselvi & Rajeswari, 2004). This is due to 
their unique tissue responses, which in principle are three types, i.e. bioinert ceramics 
(nearly inactive with the environment), bioactive ceramics (form direct chemical 
bonds with the living organism), and bioresorbable ceramics (actively participate in 
the metabolic processes of an organism). The classification of implant-tissue 
interactions are summarized in Table 2.6 (Hench & Wilson, 1993). Generally, based 
on these types, there would be tissue response, either the tissue dies, form interfacial 
bonds or replace the implant (Hench & Paschall, 1973; Black, 1984). 
Table 2.6 Classification of Implant-tissue responses (Hench & Wilson, 1993). 
Classification 
 
Tissue response Implant/ tissue 
bond 
Examples 
Toxic  Tissue dies None 
 
Lead oxide, arsenic 
oxide 
Biological nearly 
inert 
Tissue  forms an 
adherent fibrous 
capsule around the 
implant 
None 
 
Alumina, Zirconia 
and Carbon 
Bioactive Tissue forms an 
interfacial bond 
with implant 
Chemical 
 
Hydroxyapatite, Bio-
glass, A-W glass 
Bioresorbable Tissue replace 
implant 
Chemical 
 
Carbonated 
hydroxyapatite, â- 
tricalcium phosphate, 
Calcium carbonate 
 
Based on their chemical reactivity in a physiological environment as shown 
in Fig. 2.3, bioresorbable ceramics possess the higher relative reactivity followed by 
bioactive ceramics, while bioinert ceramics like alumina have essentially low relative 
reactivity (Shakelford, 1999).   
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Fig. 2.3 Relative reactivity of different type bioceramics (Shakelford, 1999) 
2.6 Calcium Phosphate Bioceramics 
 Chemical similarity to the mineral component of bones and teeth is the main 
reason for the use of calcium phosphates as bone graft substitute sources (Dorozhkin, 
2009). Calcium phosphate is known to be non-toxic, biocompatible, it is not 
recognized as alien in the body and more importantly, by a remodelling process, 
the calcium orthophosphate can integrate into living tissue. This will lead to an 
intimate physicochemical bond between the implants and bone or named as 
osteointegration (Ong & Chan, 1999), hence resulting in a positive response of 
tissues leading to bone repair.  
 There are several types of calcium orthophosphate present and these are listed 
in Table 2.7. Different Ca:P molar ratio of each compound would result in different 
types of calcium phosphates such as di-, tri-, and tetra- calcium phosphate, 
hydroxyapatite, fluoroapatite, carbonated hydroxyapatite and â-whitlockite. The 
properties of these various calcium phosphates are different and hence they are used 
in different applications, as indicated in the same table. Bioresorption and bioactivity 
are the most important properties of calcium phosphate, and they are essentially 
dynamic and strongly depend on biological parameters. This includes the interaction 
Relative 
reactivity 
Resorbable 
(e.g., TCP) 
Surface reactive 
(e.g., bioGlass) 
Nearly inert 
(e.g., Al2O3) 
10-1 1 10 102 103 104 105 
t (days) 
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with collagen and accumulation of proteins and cells on the surface of the material, 
subsequently followed by resorption of the material and formation of bone 
(Thamaraiselvi & Rajeswari, 2004). 
Table 2.7 Calcium phosphate used as biomaterials                               
(LeGeros & LeGeros, 2003) 
Compound Chemical formula Ca: P 
molar 
ratio 
Applications 
Monocalcium phosphate 
monohydrate (MCPM) 
Ca (H2PO4)2 0.5 Cements, 
polyphosphates 
Dicalcium phosphate 
dehydrate (DCPD) 
CaHPO4.2H2O 1.0 Cement, coating 
Dicalcium phosphate 
anhydrous (DCPA) 
CaHPO4 1.0 Cement, coating 
Octacalcium phosphate 
(OCP) 
Ca8H2(PO4)6.5H2O 1.33 Coating, bonegraft 
Alpha tricalcium 
phosphate (á- TCP) 
Ca3(PO4)2 1.50 Cements 
Beta tricalcium 
phosphate (â- TCP) 
Ca3(PO4)2 1.50 Cement, bone graft 
composites 
Calcium deficient apatite 
(CDA) 
Ca3(PO4)2 < 1.67 Cement, bone graft 
composites 
Hydroxyapatite (HA) Ca10 (PO4)6 (OH)2 1.67 Bone graft, coatings 
Fluoroapatite (FA) Ca10 (PO4)6 F2 1.67 Bone graft, coatings 
Carbonated 
hydroxyapatite (CHA) 
(Ca, Na)10 (PO4, CO3)6 (OH)2 1.7- 2.6 Bonegraft 
 
Tetracalcium phosphate 
(TTCP) 
Ca (PO4)2 O 2.0 Cements 
 
 The stability of calcium phosphate is reported to have increased with 
increasing Ca:P molar ratio (Bilotte, 2003). Slight differences in composition and 
structure of calcium phosphate compounds may have significant effect on their in 
vivo behaviour. Bohner (2000) reported that the main characteristic of calcium 
phosphate is probably its solubility in water because in vivo behaviour of calcium 
phosphate can be predicted to a large extent by their solubility. If calcium phosphate 
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has lower solubility than the mineral bone, the calcium phosphate will degrade 
extremely slow and vice versa.  
The behaviour of calcium phosphate biomaterial in biological environment 
determines how they can be used in vivo. The most important requirement for 
calcium phosphate to be bioactive and bond to living tissue is the formation of bone 
like apatite layer on their surface. This phenomenon can be mimically in vitro by 
using chemically simulated body fluid (SBF), a protein-free solution with ion 
concentrations similar to those of human blood plasma (Tas, 2000; Thian et al., 
2002; Kukobo & Takadama, 2006). Bioactive calcium phosphate would typically 
result in apatite formation on the synthetic bone. Besides that, calcium phosphate has 
also been reported to support osteoblast adhesion and proliferation (Davies, 1996; 
Anselme, 2000). 
Nevertheless, the limitations to apply calcium phosphates as load-bearing 
biomaterials are their mechanical properties; that is, they are essentially brittle with a 
poor fatigue resistance (Suchanek & Yoshimura, 1998; Hench, 1998). For this 
reason, calcium phosphate is currently being used as fillers and coatings in 
biomedical application (Dorozhkin, 2009). However, there are wide variations in the 
mechanical properties of synthetic calcium phosphate, and these are attributed to the 
variations in the structure of polycrystalline calcium phosphate due to variations in 
manufacturing process (Bilotte, 2003).  
Park and Lakes (2007) reported that the formations of calcium phosphate 
compounds are not only dependent on Ca:P molar ratio but also on the presence of 
water, impurities, and temperature. In wet environment and at lower temperature 
(<900 °C), it is more likely that the hydroxyapatite will form while in dry 
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atmosphere and higher temperature calcium phosphate will start to undergo phase 
transformation and form tri-calcium phosphate (á- and â-) , tetracalcium phosphate 
and calcium oxide. In many cases, both types of structures exist in the final product, 
or what is known as biphasic apatite. Table 2.8 shows the general physical properties 
of calcium phosphate. 
Table 2.8 Physical properties of Calcium Phosphate                       
(Park& Bronzino, 2003) 
Properties Value 
Elastic Modulus (GPa) 4.0- 117 
Compressive Strength (MPa) 294 
Bending Strength (MPa) 147 
Vickers Hardness (GPa) 3.43 
Poissons Ratio 0.27 
Theoritical density (g/ cm3) 3.16 
 
2.6.1 Micron-Sized and Submicron-Sized Versus Nanodimensional Calcium 
Orthophosphates 
 Nanostructured materials are then defined as materials having structural 
elements with dimensions being less than 100 nm range (Moriarty, 2000). As such, 
nanocoatings would have individual layers or multilayer surface coatings in the range 
of 1-100 nm thick, nanofibers are fibers with diameter up to 100 nm and 
nanopowders are those with an average particle size of less than 100 nm. The 
advantages of nanodimensional calcium phosphate versus coarser crystals (micron- 
and submicron-sized) are shown in Fig. 2.4. These include solubility, densification, 
bioactivity, mechanical, and chemical properties (Stupp & Ciegler, 1992; Webster et 
al., 2001; Huang et al., 2004; Wang & Shaw, 2009). 
 
